Serina Therapeutics Inc. (SER)
NYSE · Healthcare
Serina Therapeutics Inc. Shareholder Equity 2017–2025
Serina Therapeutics Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Serina Therapeutics Inc. shareholder equity as of December 31, 2025: -37,000, a 105.77% decrease year-over-year.
- Serina Therapeutics Inc. shareholder equity for 2025 were -37,000, a 105.77% decrease from 2024.
- Serina Therapeutics Inc. shareholder equity for 2024 were 641,000, a 101.98% decrease from 2023.
- Serina Therapeutics Inc. shareholder equity for 2023 were -32.3M, a 14.52% decrease from 2022.
- Serina Therapeutics Inc. shareholder equity for 2022 were -37.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Serina Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-0 |
| 2024 | $1 |
| 2023 | $-32 |
| 2022 | $-38 |
| 2021 | $-12 |
| 2020 | $-5 |
| 2019 | $2 |
| 2018 | $7 |
| 2017 | $7 |
Serina Therapeutics Inc. Shareholder Equity — FAQ
Serina Therapeutics Inc. (SER) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SER's shareholder equity history?
The chart and table above show Serina Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.